← Back to headlines




Syndax Pharmaceuticals Shows Strong Performance Amid Demand for Key Drugs
Syndax Pharmaceuticals Inc. is reportedly in a strong financial position, driven by robust demand for its flagship pharmaceutical products.
2 Mar, 07:57 — 2 Mar, 07:57
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories

Dijete u Visokom preminulo od meningokokne sepse, 35 osoba pod zaštitnom terapijom
10m ago
Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511
14m ago
Esperion Therapeutics Inc (ESPR) Strengthens Business Outlook Amid Strategic Agreements
14m ago

A terhes nők agya tényleg veszíthet a méretéből, és ennek kulcsfontosságú szerepe lehet az anyává válásban
14m ago